NcGRA2 as a molecular target to assess the parasiticidal activity of toltrazuril against Neospora caninum by STROHBUSCH, M. et al.
NcGRA2 as a molecular target to assess the parasiticidal
activity of toltrazuril against Neospora caninum
M. STROHBUSCH1, N. MU¨LLER1, A. HEMPHILL1, G. GREIF2 and B. GOTTSTEIN1*
1 Institute of Parasitology, University of Berne, Laenggass-Strasse 122, CH-3012 Berne, Switzerland
2Bayer HealthCare AG, Leverkusen, Germany
(Received 19 December 2007; revised 27 February and 23 April 2008; accepted 28 April 2008; ﬁrst published online 13 June 2008)
SUMMARY
The treatment of Neospora caninum infection in the bovine host is still at an experimental stage. In contrast to the in vivo
situation, a wide range of compounds have been intensively investigated in cell-culture-based assays. Tools to demonstrate
eﬃcacy of treatment have remained conventional including morphological and cell biological criteria. In this work, we
present a molecular assay that allows the distinction between live and dead parasites. Live parasites can be detected by
measuring the mRNA level of speciﬁc genes, making use of the speciﬁc mRNA available in live cells. The NcGra2 gene
ofN. caninum, which is known to be expressed in both tachyzoites and bradyzoites, was used to establish a quantitative real-
time RT-PCR, for monitoring parasite viability. Validation of the system in vitro was achieved using Neospora-infected
cells that had been treated for 2–20 days with 30 mg/ml toltrazuril.NcGRA2-RT-real time PCRdemonstrated that a 10-day
toltrazuril-treatment exerted parasitostatic activity, as assessed by the presence of NcGRA2-transcripts, whereas after a
14-day treatment period no NcGRA2-transcripts were detected, showing that the parasites were no longer viable.
Concurrently, extended culture for a period of 4 weeks in the absence of the drug following the 14-day toltrazuril treatment
did not lead to further parasite proliferation, conﬁrming the parasiticidal eﬀect of the treatment. This assay has the potential
to be widely used in the development of novel drugs againstN. caninum, with a view to distinguishing between parasiticidal
and parasitostatic eﬃcacy of given compounds.
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INTRODUCTION
The main problem associated with the apicomplexan
parasite Neospora caninum and the corresponding
disease, neosporosis, is abortion in cattle (Dubey,
2003), which represents a serious veterinary health
and economic problem within livestock production
(Hemphill and Gottstein, 2000; Dubey et al. 2007).
So far, eﬃcacy of experimental treatment and
vaccination in vitro or in vivo has been deter-
mined upon use of morphological criteria of aﬀected
parasites (microscopy or TEM), diﬀerential dem-
onstration of the absence or presence of parasite-
induced lesions upon (immuno-) histology, and
PCR-based detection of parasite DNA in such
lesions and aﬀected organs (Kritzner et al. 2002;
Darius et al. 2004b ; Esposito et al. 2005). However,
the presence of parasite DNA or antigens in infected
tissue does not necessarily provide information on
parasite viability, and conventional in vivo/in vitro
tests are being used by inoculating appropriate
samples intomice or cell cultures (Dubey et al. 2007).
Since these methods can often be time-consuming
and inconclusive, we tackled the problem by ad-
dressing parasite mRNA as a target to demonstrate
viability or non-viability of organisms. Although the
genome of N. caninum is not yet fully described,
several genes could be identiﬁed by comparison with
the related parasite Toxoplasma gondii. Immuno-
screening of a cDNA library derived from mRNA of
N. caninum tachyzoites resulted in the identiﬁcation
of a clone with a deduced protein sequence exhibiting
a signiﬁcant homology of the gene product to the
28 kDa (GRA2) antigen of T. gondii (Ellis et al.
2000). In T. gondii the TgGra2 gene product is an
excreted-secreted antigen, which is stored in the
dense granules and secreted in the parasitophorous
vacuole after host cell invasion (Mercier et al. 1993).
Since the corresponding mRNA was abundantly
present in N. caninum tachyzoites, it was assumed
that the gene is highly expressed in this stage (Ellis
et al. 2000). The TgGra2 gene of T. gondii was found
to be constitutively expressed in both, tachyzoites
and bradyzoites (Manger et al. 1998). In N. caninum
the NcGRA2 protein was found to be associated with
the parasitophorous tubular network in tachyzoites
and incorporated into the cyst wall of in vitro derived
bradyzoites (Vonlaufen et al. 2004).
The need for the development of eﬀective pro- or
metaphylactic measures against bovine neosporosis
has been widely addressed and discussed (Kritzner
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et al. 2002; Gottstein et al. 2001; Innes et al. 2002;
Ha¨sler et al. 2006a, b). Chemotherapy is being
discussed as an interesting alternative to the vacci-
nation strategy (Ha¨sler et al. 2006a, b). Toltrazuril,
a symmetric triazinone derivative, was shown to
exhibit anti-coccidial activity against cyst-forming
and non-cyst-forming coccidians (Haberkorn, 1996).
The eﬀects of toltrazuril on the ﬁne structure and
multiplication of N. caninum were studied in cell
culture employing light and electron microscopy
(Darius et al. 2004b). The authors demonstrated
considerable damage, induced in N. caninum tachy-
zoites that were incubated in 30 mg/ml toltrazuril
for periods of up to 12 h, and they concluded that
the drug was exhibiting parasiticidal activity. In the
murine model of experimentalN. caninum infection,
toltrazuril treatment prevented severe clinical signs
and the formation of cerebral lesions (Gottstein et al.
2001; Darius et al. 2004a). However, Ammann
et al. (2004) clearly demonstrated that an eﬃcient
metaphylaxis requires at least a T-cell-mediated
immunological support in mice. We now used
NcGra2 as a target gene to demonstrate viability
or non-viability of N. caninum in aﬀected host cells
following treatment with the anti-parasitic com-
pound toltrazuril.
MATERIALS AND METHODS
Tissue-culture media, biochemicals and drugs
If not otherwise stated, all tissue-culture media were
purchased from Gibco-BRL (Basel, Switzerland)
and biochemical reagentswere fromSigma (StLouis,
MO). Toltrazuril formulated for tissue culture was
provided by Dr Gisela Greif (Bayer HealthCare AG,
Germany), stock solutions at 30 mg/ml were pre-
pared in dimethyl sulfoxide (DMSO) and stored at
4 xC for not longer than 1 month.
Tissue culture and parasite puriﬁcation
Cultures of Vero cells were maintained in RPMI
1640 medium (Gibco-BRL) supplemented with 5%
fetal calf serum (FCS), 4 mM L-glutamine and
100 U/ml penicillin G, 100 mg/ml streptomycin and
0.25 mg/ml amphotericin B at 37 xC with 5% CO2.
Cultures were trypsinized at least once a week.
Human foreskin ﬁbroblasts (HFF) were maintained
in Dulbecco’s modiﬁed Eagle’s medium (DMEM)
containing the same additives and were identically
treated. N. caninum (Nc-1 and Nc-Liverpool iso-
lates) and T. gondii (RH isolate) tachyzoites were
maintained in Vero cell monolayer cultures, during
which time FCS was replaced with immunoglobulin
G-free horse serum. Tachyzoites were harvested
when they were still intracellular by trypsinization
of infected Vero cells followed by repeated passage
through a 25-gauge needle. Host cell debris was
removed from the parasites by separation on
Sephadex-G25 columns as previously described
(Hemphill et al. 1996). The tachyzoites were counted
using a Neubauer chamber and cell pellets were
frozen atx80 xC prior to DNA and RNA extraction
to develop and examine the sensitivity and speciﬁcity
of the PCR. Furthermore, freshly isolated and
counted parasites were diluted for in vitro drug
treatment assays.
Host cell infection and in vitro drug
treatment assays
HFF were grown to conﬂuent monolayer in 24-well
tissue-culture plates and infected with 5r104 pu-
riﬁed Nc-1 tachyzoites per well for 2 h at 37 xC with
5% CO2, as previously described (Esposito et al.
2005). Unbound parasites were removed by washing
in DMEM, and infected monolayers were main-
tained in supplemented DMEM containing the
indicated drug concentration (see below). Controls
contained the appropriate amounts of the solvent
DMSO alone. The cultures were maintained under
treatment at 37 xC with 5% CO2 for various periods
of time and checked daily by light microscopy.
DMSO- or drug-containing medium was changed
every day. A control experiment was done to speciﬁ-
cally assess the eﬀect of the solvent DMSO alone on
the parasite proliferation and survival in infected
HFF monolayers. Infected monolayers were main-
tained under DMSO treatment or in the absence of
DMSO for 20 days. DMSO was used in a 1 : 1000
dilution, corresponding to the DMSO concentration
in drug-containing medium. Samples for monitoring
parasites were collected (as indicated below) on days
0, 3, 5, 7, 11 and 20, following initiation of the
treatment. In experimental part 1, diﬀerent concen-
trations of toltrazuril were tested. Infected mono-
layers were maintained in medium containing 30,
60 or 90 mg/ml toltrazuril for 2 days. Samples were
collected as indicated below. In experimental part 2,
the short-term eﬀect of toltrazuril on infected
monolayers was assessed. Therefore, infected mono-
layers were treated with 30 mg/ml toltrazuril or a
corresponding amount of DMSO solvent for 2 days.
Samples for monitoring parasite survival by RT-
PCRwere taken at day 0, 1 and 2, following initiation
of the treatment. Experimental part 3 investigated
the long-term eﬀect of toltrazuril and the putative
recurrence of the proliferative activity of the treated
parasites. For this, infected monolayers were treated
with 30 mg/ml toltrazuril for 3–20 days. The follow-
up analyses of DMSO-treated control cultures were
stopped after 6 days, as the control experiment did
not show a negative eﬀect of DMSO (Fig. 2).
Samples for monitoring parasite survival by RT-
PCR were taken at days 3, 10, 14 and 20, following
initiation of drug treatment. Furthermore, infected
monolayers were trypsinized at day 3, 10 and 14 and
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washed in DMEM. After centrifugation, the pellet
was resuspended in 4 volumes of supplemented
DMEM, added to 4 wells with fresh HFF mono-
layers andmaintained for up to 32 days in the absence
of the drug.
Experimental part 4 was designed to assess the
eﬀect of toltrazuril on an established in vitro infec-
tion. For this, HFF monolayers were infected and
parasites were subsequently allowed to proliferate
in the absence of the drug. After 3 days, 30 mg/ml
toltrazuril was added and the cultures were main-
tained for another 4 days under treatment.
For sample collection, the medium was removed
and wells were washed with PBS. The cellular
material was taken up in 400 ml of RTL+ buﬀer
(AllPrep DNA/RNA kit; QIAGEN, Basel, Switzer-
land) containing 1% b-mercaptoethanol, then trans-
ferred to Eppendorf tubes and frozen at x80 xC
prior to DNA and RNA extraction. Each assay in a
given experiment was carried out in triplicate.
DNA/RNA extraction and cDNA synthesis
DNA and RNA puriﬁcation were performed using
the AllPrep DNA/RNA kit (QIAGEN) according
to the standard protocol suitable for cell cultures.
Frozen cell pellets were lysed in 750 ml of RTL+
buﬀer containing 1% b-mercaptoethanol. Frozen
lysates were allowed to thaw at 37 xC. All puriﬁcation
steps were performed at room temperature. DNA
was eluted in 60 ml of AE buﬀer and RNA in 60 ml
of RNAse-free water. DNA was boiled at 95 xC
for 3 min and frozen atx80 xC prior to PCR. RNA
was boiled at 95 xC for 3 min and immediately used
for cDNA synthesis.
Reverse Transcription
cDNA synthesis was performed using the Omni-
script1 Reverse Transcription kit (QIAGEN) ac-
cording to the standard protocol for ﬁrst-strand
cDNA synthesis. Brieﬂy, 0.5 mg random Primer
(Promega,Wallisellen, Switzerland) and 2 ml of RNA
were used in a ﬁnal volume of 20 ml reaction mix
and incubated for 1 h at 37 xC. cDNA was boiled at
95 xC for 3 min and frozen atx80 xC prior to PCR.
Conventional PCR
Detection of parasite-speciﬁc DNA by Nc5-PCR
was done as previously described (Mu¨ller et al. 1996)
with N. caninum-speciﬁc primers Np21plus and
Np6plus in a thermal cycler (Gene Amp PCR
System model 9700; Applied Biosystems, Basel
Switzerland). For the mix, 20 pmol of each primer
and 1 ml of DNA in a ﬁnal volume of 25 ml were used.
For detection of parasite-speciﬁc cDNA, the for-
ward primer NcGRA2-F1 (5kGATGATGTTA-
GAGAATCAATGGC 3k) and the reverse primer
NcGRA2-R2 (5kCCGTCCTTCTCCATCGTCC
3k) were designed using nucleotide sequence data
available from the GenBank databases (http://
www.ncbi.nlm.nih.gov/GenBank/index.html) under
the Accession number AF196293. PCR was per-
formed using 25 pmol of each primer and 1 ml of
cDNA in a ﬁnal volume of 25 ml in a thermal cycler
for 40 cycles (94 xC, 30 sec; 60 xC, 30 sec; 72 xC,
2 min), followed by a ﬁnal primer extension at 72 xC
for 15 min. The PCR ampliﬁed a product of 486 bp
of the NcGra2 gene (Fig. 1A).
Both PCR-mixes were performed using the
AmpliTaq1 DNA polymerase kit (Applied Bio-
systems). To prevent carry-over contamination from
previous reactions, the samples were incubated with
uracyl DNA glycosylase (UDG; Roche Diagnostics,
Basel, Switzerland) for 10 min at 20 xC. The UDG
was inactivated by incubation at 95 xC for 2 min.
Each run included a negative (water) and a positive
(puriﬁed parasites) sample.
Quantitative real-time PCR
Quantitative real-time Nc5-PCR based on DNAwas
performed on the LightCycler instrument (Roche
Diagnostics) as previously described (Mu¨ller et al.
2002) using N. caninum-speciﬁc primers Np21plus
and Np6plus, Nc5-speciﬁc hybridization probes
3FL and 5CL and 1 : 410 diluted DNA.
Quantitative real-time RT-PCR based on cDNA
was performed using the QuantiTecTMSYBR1
Green PCR kit (QIAGEN), gene-speciﬁc primers
NcGRA2-F1 and -R2 and 1 : 41 diluted cDNA.After
activation of the DNA polymerase for 15 min at
95 xC, PCR was performed for 50 cycles (94 xC,
15 sec; 58 xC, 15 sec; 72 xC, 30 sec) with a single
acquisition mode at 85 xC, followed by a melting
curve. Both PCRs were performed with 4.1 ml of
sample in a ﬁnal volume of 10 ml. To avoid carry-over
contamination, UDG was added to the mix. As ex-
ternal standards, samples containing DNA or cDNA
equivalents from 100, 10 and 1 N. caninum tachy-
zoite(s) were included. Parasite number was cal-
culated by assessing mean values (plus standard
deviations) from triplicate determinations.
Quantitative real-time RT-PCR for the ampliﬁ-
cation of host cell a-actin was performed using the
QuantiTecTMSYBR1Green PCR kit (QIAGEN) as
described previously (Mu¨ller et al. 2003). The PCR
included forward primer a-ac1, reverse primer a-ac2
and 4 ml of 1 : 10 diluted cDNA in a 10 ml standard
reaction.
Statistical analysis
For time-course experiments, the signiﬁcance of
the diﬀerences between end-point values of the
control and experimental assays was determined by
Student’s t test, using the Microsoft Excel program.
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P values of <0.05 were considered statistically sig-
niﬁcant.
RESULTS
Sensitivity and speciﬁcity of PCR
The nucleotide sequence of the NcGRA2 gene was
derived from theGenBank database under Accession
number AF196293. A primer pair was designed that
included the exon/exon fusion side of the gene. The
product ampliﬁed by conventional PCR using cDNA
had a size of 468 bp (Fig. 1A). To assess the sensi-
tivity of the RT-PCR, cDNA samples from puriﬁed
Nc-1 tachyzoites were run at diﬀerent dilutions
(Fig. 1A). Visualization of the PCR products showed
an end-point sensitivity of 0.1 parasite equivalents
per PCR reaction. The PCR was speciﬁc for cDNA
as there was no detectable product after the ampli-
ﬁcation of the same amount of parasite DNA (data
not shown). For quantiﬁcation of the number of
parasites in a given sample, the conventional
RT-PCRwas transformed into a real-timeRT-PCR.
The sensitivity of the real-time RT-PCR was de-
termined with cDNA samples from puriﬁed Nc-1
tachyzoites at diﬀerent dilutions (Fig. 1B). The real-
time RT-PCR showed an end-point sensitivity of
0.1 parasite equivalents per PCR reaction. To test
the species speciﬁcity, conventional RT-PCR was
carried out with NcLiv tachyzoites and Toxoplasma
RH tachyzoites. The PCR was positive forNeospora
tachyzoites but negative for Toxoplasma tachyzoites
(data not shown).
In vitro treatment with toltrazuril
The NcGRA2-RT-PCR-assay was used to assess
the eﬃcacy of toltrazuril in vitro. As toltrazuril was
dissolved in DMSO, a control experiment was
carried out to determine the eﬀect of the solvent
DMSO on parasite proliferation and survival.
DMSO had no negative eﬀect on parasite survival, as
quantitative real-time RT-PCR detected similar
amounts of parasites in the DMSO-treated and
-untreated cultures after 20 days (Fig. 2). Due to the
fact, that the tachyzoites egressed and destroyed
most of the host cell monolayer, a decrease of para-
sites was observed from day 5 onwards in both,
DMSO-treated and -untreated cultures.
Diﬀerent concentrations of toltrazuril were tested
on infected HFF host cells in vitro. Cultures were
grown in medium containing 30, 60 or 90 mg/ml
toltrazuril for 2 days. Quantitative real-time RT-
PCR revealed no diﬀerence in the parasite amount
between the 3 used concentrations (data not shown).
Therefore, all further experiments were done with
a toltrazuril concentration of 30 mg/ml. To assess
the short-term eﬀect of toltrazuril, infected cell cul-
tures were grown in drug-containing medium for
2 days. A signiﬁcant diﬀerence in the parasite
number was ﬁrst observed after 2 days of treatment
when compared with the untreated culture (Fig. 3).
Fig. 1. NcGRA2-RT-PCR sensitivity. cDNA was diluted and conventional PCR (A) and real-time RT-PCR (B) was
performed using the NcGRA2-speciﬁc primers. Dilutions included 100 (2), 10 (3), 1 (4), 0.1 (5), 0.01 (6) or 0.001
(7) parasite equivalents. For the real-time RT-PCR every dilution was performed in duplicate. Using cDNA, the PCR
ampliﬁed a product of 468 bp. M: DNA-marker WX174; 1: negative control.
M. Strohbusch and others 1068
https:/www.cambridge.org/core/terms. https://doi.org/10.1017/S0031182008004599
Downloaded from https:/www.cambridge.org/core. University of Basel Library, on 30 May 2017 at 12:52:24, subject to the Cambridge Core terms of use, available at
Longer-term treatment assays were carried out to
determine the treatment duration necessary for
parasiticidal activity (Fig. 4). Quantitative real-time
NcGRA2-RT-PCR was unable to detect any para-
sites after a 14-day-treatment period (Fig. 4A). A
comparison of the parasite numbers, calculated by
means ofDNA and cDNA, revealed that DNA is still
detectable after 14 days of drug treatment, while no
NcGRA2-RNA is being produced anymore at this
time-point, indicating that the tachyzoites detected
by real-time PCR were non-viable (Fig. 4B). In
order to verify this, the infected and drug-treated
cultures weremaintained after the treatment in drug-
free medium for up to 4 weeks (Fig. 4C). Neospora
was able to restart proliferation even after 10 days of
exposure to toltrazuril. However, no recurrence of
the parasite in cell culture was observed after the
treatment period of 14 days. Furthermore, quanti-
tative real-time PCR, based onDNA and cDNA, did
not detect any parasites in the culture samples. Host
cells were not negatively aﬀected by the treatment, as
microscopical observation showed no morphological
alterations to indicate destruction. Further, the
host cell a-actin transcription level, detected by
quantitative real-time RT-PCR, remained constant
over the treatment period (data not shown).
Toltrazuril also acts against an established in vitro
infection of host cells with Neospora. Cultures were
infected and grown for 3 days in the absence of the
drug. Addition of toltrazuril, after establishment of
the infection in vitro, reduced the parasite number
(Fig. 5).
DISCUSSION
The apicomplexan parasite Neospora caninum is an
obligate intracellular parasite, infection of which is
associated with abortion in cattle. To date, there is no
eﬀective treatment for cattle available (Andrianarivo
et al. 2000; Innes and Vermeulen, 2006) but a con-
siderable number of potentially useful compounds
were tested in cell-culture-based assays (Lindsay and
Dubey, 1989; Lindsay et al. 1994). In most cases, the
eﬀects of a given compound were microscopically
examined (Darius et al. 2004b), or parasite numbers
were determined either by microscopical counting of
the parasites or by extraction of DNA and quanti-
tative real-time PCR (Esposito et al. 2005). However,
while these techniques provided information on the
proliferation inhibitory eﬀects of a given compound,
Fig. 3. Short-term eﬀect of toltrazuril. HFF monolayers
were infected with Neospora caninum tachyzoites, and at
2 h p.i. 30 mg/ml toltrazuril (Tol) was added. Samples
were collected at day 0 and days 1 and 2 p.i. The y-axis
shows the number of parasite equivalents per quantitative
real-time NcGRA2-RT-PCR. There is a signiﬁcantly
lower amount of parasites at 2 days p.i. in the toltrazuril-
treated sample compared to the DMSO control
(* P<0.05).
Fig. 2. Eﬀect of the solvent DMSO on parasite proliferation and survival. HFF monolayers were infected with
Neosporum caninum tachyzoites, and at 2 h p.i. DMSO (1 : 1000) was added. The control cultures contained medium
without DMSO. Treatment was stopped at 3, 5, 7, 11 and 20 days p.i. The y-axis shows the number of parasite
equivalents per quantitative real-time NcGRA2-RT-PCR (detection of Neospora cDNA; ﬁlled line) and quantitative
real-time Nc5-PCR (detection of Neospora genomic DNA; dotted line). The amount of parasites decreased from day 5
on, due to the lysis of the host cells.
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they did not allow distinction between live and dead
parasites following a given treatment. The aim of
the present study was to develop a method that
could be used to distinguish between live and dead
N. caninum parasites. To validate the method,
Neospora tachyzoites were treated in vitro with
toltrazuril, a drug that was shown earlier to exhibit
considerable anti-parasitic activity against N. cani-
num (Gottstein et al. 2001; Darius et al. 2004a, b).
To detect only the live parasites, we developed a
PCR using cDNA based on mRNA of the NcGRA2
gene, making use of the speciﬁc mRNA of an anti-
gen that is expressed in both tachyzoite and brady-
zoite stages. The NcGRA2 gene sequence contains
2 exons and 1 intron and is highly expressed in
tachyzoites (Ellis et al. 2000). The dense granule
protein NcGRA2 was also detected in in vitro-
derived bradyzoites (Vonlaufen et al. 2004). The
Fig. 4. Long-term eﬀect of toltrazuril and re-start of parasite proliferation. HFF monolayers were infected with
Neospora caninum tachyzoites, and at 2 h p.i. 30 mg/ml toltrazuril (Tol) was added. (A) Treatment was stopped at 3, 10,
14 and 20 days p.i. The y-axis shows the number of parasite equivalents per quantitative real-time NcGRA2-RT-PCR.
As assessed by NcGRA2-RT-PCR, there was no detectable parasite in the sample after 14 and 20 days of treatment. (B)
Comparison of parasite numbers, as detected by quantitative real-time Nc5-PCR (detection of Neospora genomic DNA)
and quantitative real-time NcGRA2-RT-PCR (detection of Neospora cDNA). Note that there is still genomic DNA but
no detectable cDNA in the 14-day treated sample. (C) After the indicated treatment duration, cultures were maintained
without DMSO (after 3 days, open arrow) or toltrazuril (after 3, 10 and 14 days, closed arrows) for up to 4 weeks. Note
that no restart of proliferation was observed after 14 days of treatment. There is a signiﬁcantly lower amount of
parasites in the toltrazuril-treated samples compared to the DMSO control at days 3 and 6 p.i. (* P<0.05).
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NcGRA2-RT-PCR developed herein was speciﬁc
for cDNA derived from N. caninum Nc-1 and
Nc-Liverpool strain tachyzoites. As the NcGRA2-
speciﬁc primers included the exon/exon fusion site,
the NcGRA2 DNA sequence was not ampliﬁed in
this reaction. Despite a 56% similarity between the
Neospora and theToxoplasmaGRA2 sequences (Ellis
et al. 2000), the NcGRA2-RT-PCR was highly
speciﬁc for the NcGRA2 sequence. These obser-
vations indicated that the new NcGRA2-RT-PCR
should be considered as a useful tool to detect live
Neospora parasites, especially due to its high sensi-
tivity of 0.1 parasite equivalents per reaction.
To validate the NcGRA2-RT-PCR, in vitro
treatment of N. caninum with toltrazuril was per-
formed. The solvent DMSO itself has no negative
eﬀect on parasite survival. Similar amounts of para-
sites were found in DMSO-treated and -untreated
cultures after a time-period of 20 days. Previous
studies had already indicated that toltrazuril exhibits
profound anti-parasitic activity, inducing consider-
able damage in N. caninum tachyzoites upon in vitro
treatment and limiting parasite proliferation and
dissemination in experimentally infected mice and
cattle (Gottstein et al. 2001, 2005; Kritzner et al.
2002; Darius et al. 2004a, b ; Haerdi et al. 2006).
After microscopical examination of in vitro tol-
trazuril (30 mg/ml)-treated parasites, Darius et al.
(2004b) observed severe destruction that was pro-
posed to be lethal. In the cell-culture assay presented
in this work, the treatment with 30 mg/ml toltrazuril
revealed a signiﬁcant reduction in the number
of parasites after 2 days in treated cultures when
compared to untreated cultures. Nevertheless, the
2-day-treated cultures contained viable parasites, as
shown by the detection of NcGRA2 mRNA. This
is conﬁrmed by the fact that parasites treated for a
few days were able to infect new host cells and started
proliferation again in the absence of toltrazuril.
Thus, when applied for a few days under these ex-
perimental conditions, toltrazuril exhibits only para-
sitostatic activity. In experimentally infected mice a
6-day toltrazuril treatment also had a more para-
sitostatic rather than a parasiticidal eﬀect (Ammann
et al. 2004). A clear parasiticidal eﬀect of toltrazuril,
deﬁned in our assay by the failure to detectNcGRA2
mRNA, was ﬁrst observed after a continuous long-
term treatment of 14 days. However, N. caninum
DNA was still detectable in the 14-day-treated
samples, but the parasites were not viable anymore
since they were not able to restart proliferation fol-
lowing drug treatment. Toltrazuril acts speciﬁcally
against the parasites, as the number of host cells was
not aﬀected after the long-term treatment.
In naturally infected animals, usually an estab-
lished infection has to be treated. In our culture-
based assay presented here, toltrazuril could
markedly reduce the number of parasites after a
3-day established infection.
In conclusion, we present a novel assay that allows
distinction between live and dead N. caninum in
cell culture. This assay is applicable, for example, in
eﬃcacy testing of chemotherapeutically interesting
compounds, and was validated with respect to the
in vitro eﬃcacy of toltrazuril, a drug that is currently
being experimentally assessed for the potential
treatment of neosporosis in cattle. The fact, that
at least 14 days of in vitro treatment is necessary
to obtain parasiticidal activity of toltrazuril, has im-
portant implications for the development of novel
treatment strategies for neosporosis in cattle. Further
investigations will focus on optimizing this RT-PCR
for the detection of live parasites in the tissues of
infected animals. Furthermore, we would also like
to address the question of whether other stages of
the parasite, such as bradyzoites, can be aﬀected by
medication, and if the NcGRA2 mRNA approach
can also be used to determine the viability status of
fully mature N. caninum tissue cysts.
The study was supported by Bayer HealthCare AG
(Leverkusen), the Swiss Federal Oﬃce of Science and
Education (BBW C01.0122 in the frame of COST 854),
and the Swiss National Science Foundation (Grant No.
3100A0-112532).
Fig. 5. Eﬀect of toltrazuril on an established Neospora caninum infection. Infected ﬁbroblasts were grown for 3 days
without toltrazuril to establish an infection. Treatment started 0 (open arrow) or 3 (closed arrow) days p.i. Note that
toltrazuril treatment reduced the number of parasites after an established infection, as assessed by quantitative real-time
NcGRA2-RT-PCR.
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